Inatriatofanewdrugcompared with standard therapv,theriskof complications inthecontroLarm is 2.4%
andtheriskofcomplicationsinthetreatmemtarm is1.8.
Whatistheabsouuteriskreduction associated withthenewtreatment?
0.6%
1.8%
2.46
25%
33%
@1MINENDOCRINE
